0001209191-13-047200.txt : 20131003 0001209191-13-047200.hdr.sgml : 20131003 20131003163833 ACCESSION NUMBER: 0001209191-13-047200 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131002 FILED AS OF DATE: 20131003 DATE AS OF CHANGE: 20131003 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SafeStitch Medical, Inc. CENTRAL INDEX KEY: 0000876378 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 112962080 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4400 BISCAYNE BLVD. STREET 2: SUITE A-100 CITY: MIAMI STATE: FL ZIP: 33137 BUSINESS PHONE: 305-575-4600 MAIL ADDRESS: STREET 1: 4400 BISCAYNE BLVD. STREET 2: SUITE A-100 CITY: MIAMI STATE: FL ZIP: 33137 FORMER COMPANY: FORMER CONFORMED NAME: CELLULAR TECHNICAL SERVICES CO INC DATE OF NAME CHANGE: 19930328 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SLATTERY JOSEPH P CENTRAL INDEX KEY: 0001246530 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19437 FILM NUMBER: 131134223 MAIL ADDRESS: STREET 1: C/O SAFESTITCH MEDICAL, INC. STREET 2: 635 DAVID DRIVE, SUITE 300 CITY: MORRISVILLE STATE: NC ZIP: 27560 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2013-10-02 0 0000876378 SafeStitch Medical, Inc. SFES.OB 0001246530 SLATTERY JOSEPH P C/O TRANSENTERIX, INC. 635 DAVIS DRIVE, SUITE 300 MORRISVILLE NC 27560 0 1 0 0 EVP and CFO Series B Convertible Stock 0.40 Series B Convertible Stock 250000 I Held by Reporting Person and Spouse, as JTWROS On September 17, 2013, SafeStitch Medical, Inc. (the "Issuer") sold and issued to the Reporting Person and his spouse, as JTWROS, in a privately negotiated transaction pursuant to a securities purchase agreement, an aggregate of 25,000 shares of the Issuer's Series B convertible preferred stock at a purchase price of $4.00 per share. Upon the filing of an Amended and Restated Certificate of Incorporation by the Issuer with the State of Delaware, each share of the Issuer's Series B convertible preferred stock will automatically convert into ten (10) shares of the Issuer's common stock. The Series B Preferred Stock has no expiration date. Joseph P. Slattery 2013-10-03